Concepedia
Statistics
Publications
35
Citations
3.1K
H-Index
27
Active since
1996
Affiliations
Novartis (United States)(Current)
Novartis (Switzerland)
Pfizer (United States)
GlaxoSmithKline (United States)
Eli Lilly (United States)
Heidi J. Einolf is an author at Novartis (United States) specializing in pharmacology, pharmacokinetics, and medicine.
Top concepts
MedicinePharmacologyPharmacokineticsBiochemistryDrug DiscoveryPharmacotherapyDrug InteractionsDrug ResistancePharmacodynamic ModelingToxicology
Publications per year
1996–2020
THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE
Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 781 citations
The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective
Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · The Journal of Clinical Pharmacology · 2003 · 309 citations
Drug Interactions, Preclinical Drug Evaluation, Biochemistry +14
The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America
Scott Grimm, Heidi J. Einolf, Steven D. Hall et al. · Drug Metabolism and Disposition · 2009 · 304 citations
In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective
Valeria Chu, Heidi J. Einolf, Raymond Evers et al. · Drug Metabolism and Disposition · 2009 · 161 citations
Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans
Handan He, Phi Tran, Hequn Yin et al. · Drug Metabolism and Disposition · 2008 · 139 citations
1–5 of 35